Profitable Specialty Pharmaceuticals Company Investment Opportunity in Bangalore, India

- We are a global speciality contract research organization (CRO) headquartered in India.

- Operate mainly in India, Europe, and the Middle East. We support our clients through pharma drug development and clinical trials.

- Our company directly covers more than 20 countries and all key markets in Asia-Pacific, Japan, Europe, N. America and South Korea.

- We are a quality leader in our industry and focus on the therapeutic areas of immunology, respiratory and allergy, endocrinology, oncology, GI, and CNS based on experience and expertise.

- We have 170 pharma and R&D companies who are our clients.

- Our customers are mainly from pharma, R&D, manufacturing, fertilizers, seeds, pesticides, and diagnostics.

- Company focuses on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics, and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, and rheumatology. These include, but are not limited to, small molecules, recombinant proteins, monoclonal antibodies (mAbs), drug-delivery devices, and diagnostics in oncology and immunology.

- Due to Covid we saw an increase in the demand for our services. This is the reason for the high growth rate of our sales.

Our business model encompasses global access / early access programs, named patient programs, and securing product registrations for exclusive commercial distribution in South Asia.

Physical assets include research and development machinery and a fully equipped research lab in Mysore.

Intangible assets include intellectual approvals and patents.

We have rented offices in Bangalore of area 1,200 sq feet, a lab in Mysore of area 2,500 sq feet, and an office in the Netherlands of area 1,200 sq feet.